| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.2 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.054 | 0.2 |